Drawing for PREMIER DOCS

USPTO serial 75305666

PREMIER DOCS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
SALEMI, DOMINICK
Law office
TMEG LAW OFFICE 106 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with PREMIER DOCS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

JAMES A BARKER JR

LEGAL DEPT PREMIER INC12225 EL CAMINO REALSAN DIEGO, CA 92130UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035group purchasing of medical, surgical and other supplies and pharmaceuticals for physicians' offices, nursing homes and other non-hospital health care facilitiesACTIVEApr 8, 1997
042language translation servicesACTIVEFeb 28, 1990

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Dec 3, 2004MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Dec 3, 2004ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 11, 2004DMCCDATA MODIFICATION COMPLETED—
Oct 11, 2004ALIEASSIGNED TO LIE—
May 24, 2004MAILPAPER RECEIVED—
May 11, 2004TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 7, 2004CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 6, 2004DOCKASSIGNED TO EXAMINER—
Mar 1, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 1, 2004MAILPAPER RECEIVED—
Dec 1, 2003CFITCASE FILE IN TICRS—
Apr 7, 2003CNSLLETTER OF SUSPENSION MAILED—
Dec 2, 1997CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 28, 1997DOCKASSIGNED TO EXAMINER—
Nov 7, 1997DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance